Micafungin: A therapeutic review

Expert Review of Anti-Infective Therapy

Volumn 2, Issue 3, 2004, Pages 345-355

  Higashiyama, Yasuhito ^a   Kohno, Shigeru ^a  

^a NAGASAKI UNIVERSITY GRADUATE SCHOOL OF BIOMEDICAL SCIENCES   (Japan)

Author keywords

Aspergillosis; Candidiasis; Micafungin

Indexed keywords

AMPHOTERICIN B; ANTIFUNGAL AGENT; ANTINEOPLASTIC AGENT; CYCLOSPORIN; CYTOCHROME P450; DIAZEPAM; ECHINOCANDIN B DERIVATIVE; FLUCONAZOLE; FLUCYTOSINE; FR 901379; GLUCAN SYNTHASE; GLYCOPROTEIN P; GRISEOFULVIN; ITRACONAZOLE; LIPOPEPTIDE; METHOTREXATE; MICAFUNGIN; NYSTATIN; POLYENE ANTIBIOTIC AGENT; PYRROLE DERIVATIVE; SALICYLIC ACID; TACROLIMUS; UNCLASSIFIED DRUG; WARFARIN;

ANTIFUNGAL ACTIVITY; AREA UNDER THE CURVE; ARTHRITIS; ASPERGILLOSIS; ASPERGILLUS; CANCER CHEMOTHERAPY; CANDIDA; CANDIDIASIS; CELL WALL; CHILL; CLINICAL STUDY; CLINICAL TRIAL; DIARRHEA; DISEASE SEVERITY; DOSE RESPONSE; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG EFFICACY; DRUG ELIMINATION; DRUG ERUPTION; DRUG HALF LIFE; DRUG INDICATION; DRUG SAFETY; DRUG USE; ENZYME INHIBITION; FEVER; FUNGAL CELL; HEADACHE; HEART PALPITATION; HUMAN; HYPERTENSION; HYPOMAGNESEMIA; IN VITRO STUDY; INCIDENCE; JAPAN; KIDNEY DYSFUNCTION; LINEAR SYSTEM; LIVER DYSFUNCTION; MINIMUM INHIBITORY CONCENTRATION; MYCOSIS; NONHUMAN; PHLEBITIS; PREVALENCE; REVIEW; STRUCTURE ACTIVITY RELATION; TREATMENT OUTCOME; VOMITING;

EID: 2942602936     PISSN: 14787210     EISSN: None     Source Type: Journal    
DOI: 10.1586/14787210.2.3.345     Document Type: Review

References (29)

1. Yamazaki T, Kume H, Murase S et al. Epidemiology of visceral mycoses: analysis of data in Annual of the Pathological Autopsy cases in Japan. J. Clin. Microbiol. 37, 1732-1738 (1999).
2. Singh N. Fungal infections in the recipients of solid organ transplantation. Infect. Dis. Clin. North. Am. 17(1), 113-134, viii (2003).
3. Wakayama M, Shibuya K, Ando T et al. Deep-seated mycosis as a complication in bone marrow transplantation patients. Mycoses 45, 146-151 (2002).
4. Tomishima M, Ohki H, Yamada A et al. FK463, a novel water-soluble echinocandin lipopeptide: synthesis and antifungal activity. J. Antibiot. (Tokyo) 52, 674-676 (1999).
5. Iwamoto T, Fujie A, Sakamoto K et al. WF11899A, B and C, novel antifungal lipopeptides. Taxonomy, fermentation, isolation and physicochemical properties. J. Antibiot. (Tokyo) 47, 1084-1091 (1994).
6. Hatano K, Morishita Y, Nakai T et al. Antifungal mechanism of FK463 against Candida albicans and Aspergillus fumigatus. J. Antibiot. (Tokyo) 55, 219-222 (2002).
7. Beaulieu D, Tang J, Yan SB et al. Characterization and cilofungin inhibition of solubilized Aspergillus fumigatus (1,3)-β-D-glucan synthase. Antimicrob. Agents. Chemother. 38, 937-944 (1994).
8. Suzuki S, Terakawa M, Yokobayashi F et al. Pharmacokinetics of FK463, a novel water-soluble echinocandin-like lipopeptide, in animals. 38th Interscience Conference Antimicrob. Agents. Chemother. (1998) (Abstract F144).
9. 14 -micafungin to rats. Jpn J. Chemother. 50, 80-87 (2002).
10. Azuma J, Nakahara K, Kagoyama A et al. Pharmacokinetic study of micafungin. Jpn J. Chemother. 50, 155-184 (2002).
11. Azuma J, Nakahara K, Kagayama A et al. Phase I study of micafungin. Jpn J. Chemother. 50, 104-147 (2002).
12. 14C-FK463, a novel echinocandin antifungal, in male volunteers. J. Clin. Pharmacol. 40, 1048 (2000) (Absract 1017).
13. Azmuma J, Nakahara K, Kagayama A et al. Pharmacokinetic study of micafungin in elderly subjects. Jpn J. Chemother. 50, 148-152 (2002).
14. Townsend R. Pharmacokinetics of micafungin, an echinocandin antifungal, in subjects with severe renal dysfunction. J. Clin. Pharmacol. 42, 1054 (2002).
15. Townsend R. Pharmacokinetics of micafungin, an echinocandin antifungal, in subjects with modedrate hepatic dysfunction. J. Clin. Pharmacol. 42, 1054 (2002).
16. Seibel N, Schwartz C, Arrieta A et al. A Phase 1 study to detemine the safety and pharmacokinetics (PK) of FK463 (Echinocandin) in febrile neutropenic pediatric patients. 40th Interscience Conference Antimicrob. Agents Chemother. (2000) (Abstract 1).
17. Kaneko H, Yamato Y, Hashimoto T et al. Drug interactions of micafungin in vitro. Jpn J. Chemother. 50, 94-103 (2002).
18. Townsend R, Hebert M, Wisemandle W et al. Concomitant pharmacokinetics (PK) of micafungin, an echinocandin antifungal and cyclosporin in healthy volunteers. J. Clin. Pharmacol. 42, 1054 (2002).
19. Townsend R, Hebert M, Wisemandle W et al. Concomitant pharmacokinetics (PK) of micafungin, an echinocandin antifungal and tacrolimus in healthy volunteers. J. Clin. Pharmacol. 42, 1055 (2002).
20. Ikeda F, Otomo K, Nakai T et al. In vitro activity of a new lipopeptide antifungal agent, micafungin against a variety of clinically important fungi. Jpn J. Chemother. 50, 8-19 (2002).
21. Mikamo H, Sato Y, Tamaya T. In vitro antifungal activity of FK463, a new water-soluble echinocandin-like lipopeptide. J. Antimicrob. Chemother. 46, 485-487 (2000).
22. Kohno S, Masaoka T, Yamaguchi H. A multi-center, open-label clinical study of FK463 in patients with deep mycosis in Japan. 41st Interscience Conference Antimicrob. Agents Chemother. J-834 (2001) (Abstract J-834).
23. S Kohno. A multicenter, open-label clinical study of micafungin (FK463) in the treatment of deep-seated mycosis in Japan. Scand. J. Infect. Dis. (In press).
24. Kohno S. Clinical features of micafungin (review). Kansensho 33, 39-46 (2003).
25. Pettengell K, Mynhardt JTK. A multicenter study of the treatment of esophageal candidiasis in HIV positive patients. 40th Interscience Conference Antimicrob. Agents Chemother. (2000) (Abstract 1104).
26. van Burik J, Ratanatharathorn V, Lipton J et al. Randamized, double-blind trial of micafungin versus fluconazole for prophylaxis of invasive fungal infections in patients undergoing haematopoetic stem cell transplant. 41st Interscience Conference Antimicrob. Agents Chemother. (2002) (Abstract).
27. Powles R. Assessment of maximum tolerated dose (MTD) of micafungin (FK463) in cancer patients undergoing haematopoetic stem cell transplantation. Trends Fung. Infect. (2001) (Abstract).
28. Kohno S, Maesaki T, Iwakawa J. Synergistic effects of combination of FK463 with amphotericin B: enhanced efficacy in murine model of invasive pulmonary aspergillosis. 40th Interscience Conference Antimicrob. Agents Chemother. (2000) (Absract 1684).
29. Petraitis V, Petraitiene R, Sarafandi AA et al. Combination therapy in treatment of experimental pulmonary aspergillosis: synergistic interaction between an antifungal triazole and an echinocandin. J. Infect. Dis. 187, 1834-1843 (2003).